Photo - LuminX Biotech Co., Ltd.
58447

LuminX Biotech Co., Ltd.

Market: Medicine
Stage of the project: Operating business

Date of last change: 07.09.2022
Go to the owner's profile
2
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

LuminX was founded in 2020 with the hope of becoming the preclinical standard for all cellular products before they enter clinical trial, with the ultimate goal of being written into the guidelines.

Current Status

LuminX Tracking Kit (LTK) is not only non-toxic, stable and long-lasting, but also can label 90% of the cells on the market (recently launched the third generation of reagents to label immune cells), which meets most of the needs in clinical trials.
Currently, the company has launched three platforms for three major markets (cancer, regenerative and immune therapy), hoping to attract a large number of users to use our product/services.

Problem or Opportunity

LuminX dedicates to accelerate the optimization of cell-therapy-products through specific understanding of therapeutic cells distribution in-vivo, long-term viability, as well as their biological fate.

Solution (product or service)

With our patented LuminX Tracking Kit(LTK), out client can understand the systemic safety and biological fate of cells, estimate the outcome of cell therapy products, shorten the R&D process, and predict the clinical outcomes and improve the quality of patient’s life.

Business model

Our main business model objective is to seek commissioned cases and reagent sales with research, hospital-based and CRO companies. Move towards the simultaneous development, database increase and optimization of LuminX Tracking Kit. This process follows 3 key activities:【Cell localization, quantification and tracking】【Safety & efficacy data】【Meets FDA guidelines】

Incubation/Acceleration programs accomplishment

NBIC, iCANxIPAS, BE x TMU, Tacc+, NBRP, NHRI-TTIC
5,00
1
2
3
4
5
2 voices
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility419
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video
Presentation